Dexcom (DXCM) Receivables - Net (2010 - 2026)

Dexcom (DXCM) has 17 years of Receivables - Net data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Receivables - Net fell 5.77% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 5.77% YoY) and the FY2025 annual result came in at $1.2 billion, up 20.92% from the prior year.
• Receivables - Net slipped to $1.1 billion in Q1 2026 per DXCM's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Receivables - Net topped out at $1.3 billion in Q2 2025 and bottomed at $544.5 million in Q1 2022.
• The 5-year median for Receivables - Net is $973.9 million (2023), against an average of $904.7 million.
• The widest annual swing landed in 2024, when Receivables - Net soared 53.67%; it then declined 5.77% in 2026.
• Tracing DXCM's Receivables - Net over 5 years: stood at $713.3 million in 2022, then soared by 36.53% to $973.9 million in 2023, then gained by 3.27% to $1.0 billion in 2024, then grew by 20.92% to $1.2 billion in 2025, then declined by 10.48% to $1.1 billion in 2026.
• Per Business Quant, the three latest DXCM Receivables - Net figures stand at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison